Researchers gather for stem cell retreat

Nov 08, 2013 by Carolyn Pennington

Scientists from across the state are gathering for a retreat at the Health Center today to present their latest findings in the field of stem cell research. Among those making presentations include researchers from UConn, Yale, Wesleyan, The Jackson Laboratory, and Pfizer pharmaceuticals.

Significant findings have been made since 2005, when the General Assembly first passed legislation committing $100 million for stem cell research over 10 years. The initiative has helped support major scientific advances, state-of-the-art research facilities, and the creation of new jobs.

Marc Lalande, director of the UConn Stem Cell Institute, told the gathering that with the state's investment, UConn has been able to grow a successful stem cell community with over 40 labs and more than 70 investigators.

"We've been able to develop technology and increase economic development that is being spurred by ," explained Lalande, "and that is extremely important given the investment the state is making in Bioscience Connecticut."

Lalande went on to say that "induced pluripotent stem (iPS) cells revolutionized by allowing us to make patient specific . The UConn Stem Cell Core lab manager, Leann Crandall, has made over a 100 of these stem cells lines and has sent them all over the world. So we're extremely proud of the technology we've developed which I think is cutting edge."

This video is not supported by your browser at this time.

Among the presenters at the retreat was Dr. Ren-He Xu, director of the UConn Stem Cell Core. He discussed "Correction of a Genetic Disease in Human Stem Cells," specifically involving his research into Marfan syndrome. Using "genetic editing" techniques, Xu is getting closer to identifying potential drug therapies that could help Marfan patients.

Explore further: Why stem cells need to stick with their friends

add to favorites email to friend print save as pdf

Related Stories

Why stem cells need to stick with their friends

Nov 07, 2013

Scientists at University of Copenhagen and University of Edinburgh have identified a core set of functionally relevant factors which regulates embryonic stem cells' ability for self-renewal. A key aspect is the protein Oct4 ...

Scientists isolate new human pluripotent stem cells

Oct 31, 2013

One of the obstacles to employing human embryonic stem cells for medical use lies in their very promise: They are born to rapidly differentiate into other cell types. Until now, scientists have not been able ...

How will stem cell therapies impact patient care?

Oct 23, 2013

The stem cell field is at a critical point, with the potential for a major impact on clinical medicine if stem cell-based therapies can overcome serious and immediate challenges. These challenges and key ...

Predicting the fate of stem cells

Oct 22, 2013

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. ...

Recommended for you

YEATS protein potential therapeutic target for cancer

Oct 23, 2014

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

Oct 23, 2014

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0